New Perspectives on the Pathogenesis and Treatment of Alzheimer's Disease

Yvette C. Terrie, BSPharm, RPh
Published Online: Friday, April 27, 2012
Follow Pharmacy_Times:

Pharmacy Times Office of Continuing Professional Education


New Perspectives on the Pathogenesis and Treatment of Alzheimer's Disease

Yvette C. Terrie, BSPharm, RPh

Clinical Pharmacist/Consultant Pharmacist

Haymarket, Virginia


Yvette C. Terrie, BSPharm, RPh, has no relevant affiliations or financial relationships to disclose related to this activity.

Editorial support for this continuing education activity was provided by Elena Beyzarov, PharmD, who has no relevant affiliations or financial relationships to disclose related to this activity.

Judy V. Lum, MPA; Ann C. Lichti, CCMEP; and Donna Fausak of the Pharmacy Times Office of Continuing Professional Education have no relevant affiliations or financial relationships to disclose related to this activity.

Bea Riemschneider, Jennifer Barrio, and David Allikas of Pharmacy Times Editorial have no relevant affiliations or financial relationships to disclose related to this activity.


Educational Objectives

Upon completion of this educational activity, participants should be able to:

  1. Describe the basic etiology and pathophysiology associated with Alzheimer's disease (AD).
  2. Evaluate the epidemiology of AD, as well as its types, stages, and risk factors.
  3. Examine the pharmacist's role in counseling patients and caregivers on AD and related issues.
  4. Discuss the latest research and clinical developments with regard to AD.

Target audience: Pharmacists

Type of activity: Knowledge

Original Activity Title: The Pharmacist's Role in the Management of Alzheimer's Disease

Original Dates of Certification: January 1, 2007, to January 1, 2010

Date of Review: March 15, 2012. This activity has undergone a content review and was updated to reflect the latest research and clinical developments regarding AD.

Current Release date: April 10, 2012

Current Expiration date: April 10, 2014

Estimated time to complete activity: 2 hours

Fee: This lesson is free online

Click here to view this activity.



Related Articles
A pharmacist testified before a Senate subcommittee today that unprecedented price hikes for formerly inexpensive generic prescription drugs are “wreaking havoc” on the health care system while jeopardizing the viability of community pharmacies.
After the Drug Enforcement Administration revoked the Tampa-based pharmacy’s registration to sell controlled substances and seized its drugs, the company fought back with a lawsuit.
Roetzel & Andress LPA is pleased to announce that Ned Milenkovich, Partner and Practice Group Manager of Roetzel’s Health, Drug & Pharmacy Law group, has been elected by the Illinois State Board of Pharmacy to serve as the Board’s Vice-Chair, a position in which he has served on two prior occasions. Mr. Milenkovich will hold the position for a 1-year term.
Latest Issues
$auto_registration$